Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 14/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 7/20 | 0.65 |
| ▸ | CASP1 | P29466 | 5/20 | 0.65 |
| ▸ | CASP7 | P55210 | 3/20 | 0.65 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.65 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.61 |
| ▸ | MAPT | P10636 | 3/20 | 0.61 |
| ▸ | MEN1 | O00255 | 3/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.61 |
| ▸ | HPGD | P15428 | 5/20 | 0.58 |
| ▸ | RECQL | P46063 | 2/20 | 0.54 |
| ▸ | POLB | P06746 | 2/20 | 0.54 |
| ▸ | F2 | P00734 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 7/20 | 0.53 |
| ▸ | GLA | P06280 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3323526 | 0.93 | KDM4E (0.65) | KDM4EHSD17B10CASP1CASP7NPSR1 | |
| SCHEMBL3324497 | 0.90 | KDM4E (0.63) | KDM4EHSD17B10CASP1CASP7NPSR1 | |
| SCHEMBL3329970 | 0.88 | KDM4E (0.59) | KDM4EHSD17B10CASP1CASP7NPSR1 | |
| SCHEMBL3320375 | 0.87 | KDM4E (0.64) | KDM4EHSD17B10CASP1CASP7NPSR1 | |
| SCHEMBL13333204 | 0.84 | KDM4E (0.65) | KDM4EHSD17B10CASP1CASP7NPSR1 | |
| SCHEMBL3325600 | 0.79 | KDM4E (0.82) | KDM4EHSD17B10CASP1CASP7NPSR1 | |
| SCHEMBL15536537 | 0.78 | KDM4E (0.74) | KDM4EHSD17B10CASP1CASP7NPSR1 | |
| SCHEMBL3325353 | 0.76 | KDM4E (0.58) | KDM4EHSD17B10CASP1CASP7NPSR1 | |
| SCHEMBL3325626 | 0.76 | KDM4E (0.83) | KDM4EHSD17B10CASP1CASP7NPSR1 | |
| SCHEMBL12135787 | 0.75 | KDM4E (0.65) | KDM4EHSD17B10CASP1CASP7NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100119599-A1 | POLYHYDROQUINOLINE COMPOUNDS AND DIHYDROPYRIDINE COMPOUNDS FOR INHIBITING BETA-AMYLOID PRODUCTION | ARCHER PHARMACEUTICALS, INC. (US) | 2010-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100119599-A1 | POLYHYDROQUINOLINE COMPOUNDS AND DIHYDROPYRIDINE COMPOUNDS FOR INHIBITING BETA-AMYLOID PRODUCTION | APP, MAPT, PSEN1 | KDM4E 4115/4885HSD17B10 1530/4885CASP1 2392/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.